SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Don't Floss, You Lose - (ATRX) To the RESCUE.
ATRX 0.00010000.0%Aug 1 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: gcrispin who wrote (140)7/23/1999 7:05:00 AM
From: Arthur Radley  Read Replies (1) of 182
 
I readily admit that I read anything I can get my hands on but let me state right up front...I Don't BUY the National Enquirer!(:>)
With that stated, let me report on their July 27 edition and an article about Merv Griffin and the return of his prostate cancer:
"....the entertainer began considering NEW TREATMENT options since it's not advisable to undergo radiation treatment again. One particular therapy seems to have the edge, disclosed the close source.
"Merv told a friend he's leaning toward Lupron---a hormone. IT WOULD BE INJECTED ONCE A MONTH TO REDUCE AND DESTROY THE CANCER"."

If I'm not mistaken...ATRX is the only company working with LUPRON in such a thirty day(month) release delivery approach. It could therefore be interpreted that at least the doctor treating Merv Griffin is supportive of the ATRX method.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext